Literature DB >> 18410432

Genetic polymorphism and pathogenesis of benign prostatic hyperplasia.

Rituraj Konwar1, Naibedya Chattopadhyay, Hemant Kumar Bid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18410432     DOI： 10.1111/j.1464-410X.2008.07667.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  13 in total

1.  Coding region analysis of vitamin D receptor gene and its association with active calcium stone disease.

Authors:  Abbas Basiri; Nasser Shakhssalim; Massoud Houshmand; Amir H Kashi; Mohaddeseh Azadvari; Banafsheh Golestan; Esmaeel Mohammadi Pargoo; Hamid Pakmanesh
Journal:  Urol Res       Date:  2011-08-04

Review 2.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

3.  Clinicopathological study of prostatic biopsies.

Authors:  A Josephine
Journal:  J Clin Diagn Res       Date:  2014-09-20

4.  Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk.

Authors:  Xian-Tao Zeng; Qi-Sheng Yao; Hong Weng; Sheng Li; Jing-Yu Huang; Xing-Huan Wang
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

Review 5.  Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity.

Authors:  Anne K Mongiu; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

6.  Diagnosis and management of benign prostatic hyperplasia in primary care.

Authors:  Simon Tanguay; Murray Awde; Gerald Brock; Richard Casey; Joseph Kozak; Jay Lee; J Curtis Nickel; Fred Saad
Journal:  Can Urol Assoc J       Date:  2009-06       Impact factor: 1.862

7.  Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.

Authors:  Koo Han Yoo; Su Kang Kim; Joo-Ho Chung; Sung-Goo Chang
Journal:  J Korean Med Sci       Date:  2011-04-21       Impact factor: 2.153

8.  Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia?

Authors:  Hemant Kumar Bid; Parmeet Kaur Manchanda; Rituraj Konwar; Kasif Hanif; V Laxman Nayak; Vishwajeet Singh
Journal:  Indian J Urol       Date:  2010-10

9.  LILRA3 is associated with benign prostatic hyperplasia risk in a Chinese Population.

Authors:  Yang Jiao; Li Wang; Xin Gu; Sha Tao; Lu Tian; Rong Na; Zhuo Chen; Jian Kang; Siqun L Zheng; Jianfeng Xu; Jielin Sun; Jun Qi
Journal:  Int J Mol Sci       Date:  2013-04-24       Impact factor: 5.923

10.  Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia.

Authors:  Parmeet Kaur Manchanda; Aaron J Kibler; Mei Zhang; Janani Ravi; Hemant K Bid
Journal:  Indian J Urol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.